Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease
- PMID: 11408619
- DOI: 10.1126/science.1059581
Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease
Abstract
Huntingtin is a 350-kilodalton protein of unknown function that is mutated in Huntington's disease (HD), a neurodegenerative disorder. The mutant protein is presumed to acquire a toxic gain of function that is detrimental to striatal neurons in the brain. However, loss of a beneficial activity of wild-type huntingtin may also cause the death of striatal neurons. Here we demonstrate that wild-type huntingtin up-regulates transcription of brain-derived neurotrophic factor (BDNF), a pro-survival factor produced by cortical neurons that is necessary for survival of striatal neurons in the brain. We show that this beneficial activity of huntingtin is lost when the protein becomes mutated, resulting in decreased production of cortical BDNF. This leads to insufficient neurotrophic support for striatal neurons, which then die. Restoring wild-type huntingtin activity and increasing BDNF production may be therapeutic approaches for treating HD.
Comment in
-
Biomedicine. Huntingtin--profit and loss.Science. 2001 Jul 20;293(5529):445-6. doi: 10.1126/science.1063429. Science. 2001. PMID: 11463904 No abstract available.
Similar articles
-
Biomedicine. Huntingtin--profit and loss.Science. 2001 Jul 20;293(5529):445-6. doi: 10.1126/science.1063429. Science. 2001. PMID: 11463904 No abstract available.
-
BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice.J Neurosci. 2010 Nov 3;30(44):14708-18. doi: 10.1523/JNEUROSCI.1637-10.2010. J Neurosci. 2010. PMID: 21048129 Free PMC article.
-
Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.J Neurosci. 2004 Sep 1;24(35):7727-39. doi: 10.1523/JNEUROSCI.1197-04.2004. J Neurosci. 2004. PMID: 15342740 Free PMC article.
-
Loss of normal huntingtin function: new developments in Huntington's disease research.Trends Neurosci. 2001 Mar;24(3):182-8. doi: 10.1016/s0166-2236(00)01721-5. Trends Neurosci. 2001. PMID: 11182459 Review.
-
Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis.FEBS J. 2013 Sep;280(18):4382-94. doi: 10.1111/febs.12418. Epub 2013 Jul 31. FEBS J. 2013. PMID: 23829302 Free PMC article. Review.
Cited by
-
CNPY2 protects against ER stress and is expressed by corticostriatal neurons together with CTIP2 in a mouse model of Huntington's disease.Front Mol Neurosci. 2024 Sep 18;17:1473058. doi: 10.3389/fnmol.2024.1473058. eCollection 2024. Front Mol Neurosci. 2024. PMID: 39359687 Free PMC article.
-
Beneficial effects of miR-132/212 deficiency in the zQ175 mouse model of Huntington's disease.Front Neurosci. 2024 Aug 7;18:1421680. doi: 10.3389/fnins.2024.1421680. eCollection 2024. Front Neurosci. 2024. PMID: 39170678 Free PMC article.
-
Neuroprotection by ADAM10 inhibition requires TrkB signaling in the Huntington's disease hippocampus.Cell Mol Life Sci. 2024 Aug 7;81(1):333. doi: 10.1007/s00018-024-05382-1. Cell Mol Life Sci. 2024. PMID: 39112663 Free PMC article.
-
Multi-omic analysis of Huntington's disease reveals a compensatory astrocyte state.Nat Commun. 2024 Aug 8;15(1):6742. doi: 10.1038/s41467-024-50626-0. Nat Commun. 2024. PMID: 39112488 Free PMC article.
-
Mitochondrial targeted antioxidants as potential therapy for huntington's disease.Pharmacol Rep. 2024 Aug;76(4):693-713. doi: 10.1007/s43440-024-00619-z. Epub 2024 Jul 9. Pharmacol Rep. 2024. PMID: 38982016 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases